Hypolipidaemic and antiplatelet activity of phenoxyacetic acid derivatives related to α-asarone

Journal of Pharmacy and Pharmacology

Volumn 58, Issue 10, 2006, Pages 1343-1349

  Pérez Pastén, Ricardo ^a   García, Rosa Virginia ^b   Garduño, Leticia ^b   Reyes, Elba ^b   Labarrios, Fernando ^b   Tamariz, Joaquín ^b   Chamorro, Germán ^b  

^a UNIVERSIDAD AUTÓNOMA DEL ESTADO DE HIDALGO   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ASARONE; ANTITHROMBOCYTIC AGENT; CLOFIBRATE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHENOXYACETIC ACID DERIVATIVE; TRIACYLGLYCEROL; TYLOXAPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG INHIBITION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPOLIPEMIA; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN CONTENT; RAT; THROMBOCYTE AGGREGATION;

ACETIC ACIDS; ANIMALS; ANISOLES; ANTILIPEMIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRINOLYTIC AGENTS; HUMANS; HYPERCHOLESTEROLEMIA; HYPOLIPIDEMIC AGENTS; MALE; MICE; MICE, INBRED STRAINS; MOLECULAR STRUCTURE; PHENOXYACETATES; PLATELET AGGREGATION; RANDOM ALLOCATION; RATS; RATS, WISTAR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33750075486     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.58.10.0007     Document Type: Article

References (28)

1. Born, G. V. R. (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 927-929
2. Chamorro, G., Salazar, M., Salazar, S., Mendoza, T. (1993) Farmacología y Toxicología de Guatteria gaumeri y α-asarone. Rev. Inv. Clin. 45: 597-604
3. Chamorro, G., Garduño, L., Martínez, E., Madrigal, E., Tamariz, J., Salazar, M. (1998) Dominant lethal study of α-asarone in male mice. Toxicol. Lett. 99: 71-77
4. Cruz, A., Garduño, L., Salazar, M., Martínez, E., Díaz, F., Camorro, G., Tamariz, J. (2001) High hypolipidemic activity of saturated side-chain α-asarone analogs. Med. Chem. Res. 10: 587-595
5. Cruz, A., Salazar, M., Garciafigueroa, Y., Hernández, D., Díaz, F., Chamorro, G., Tamariz, J. (2003) Hypolipidemic activity of new phenoxyacetic derivatives related to α-asarone with minimal pharmacophore features. Drug Dev. Res. 60: 186-195
6. Dajani, E. Z., Shahwan, T. G., Dajani, N. E. (2002) Stalins, platelet aggregation and coronary heart disease. J. Assoc. Acad. Minor Phys. 13: 27-31
7. Díaz, F., Muñoz, H., Labarrios, F., Chamorro, G., Salazar, M., Morelos, M. E., Tamariz, J. (1993) Synthesis and hypolipidemic activity of some alpha-asarone analogs. Med. Chem. Res. 3: 101-109
8. Endo, A., Tsujita, Y., Kuroda, M., Tanzawa, K. (1979) Effects on ML-236B on cholesterol metabolism in mice and rats: lack of hypocholesterolemic activity in normal animals. Biochim. Biophys. Acta 575: 266-276
9. Enríquez, R. G., Chávez, M. A., Jáuregui, F. (1980) Propenylbenzenes from Guatteria gaumeri. Phytochemistry 19: 2024-2025
10. Friedwald, W. T., Levy, R. I., Fredrickson, D. S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin. Chem. 18: 499-502
11. Garduño, L., Salazar, M., Salazar, S., Morelos, M. E., Labarrios, F., Tamariz, J., Chamorro, G., (1997) Hypolipidemic activity of α-asarone in mice. J. Ethnopharmacol. 55: 161-163
12. Gómez, C., Chamorro, G., Chávez, M. A., Martínez, G., Salazar, M., Pages, N. (1987) Effet de l'α-asarone sur l'hypercholestérolemie et la cholélithiase expérimentales. Plantes Méd. Phytothér. 21: 279-284
13. Hall, J. H., Chapman, J. M., Voorstaad, P. J., Cocolas, G. H. (1984) Hypolipidemic activity of 3-N-(1′, 8′-napthalimido) propionic acid in rodents. J. Pharm. Sci. 73: 956-960
14. Huff, M. W., Burnett, J. R. (1997) 3-Hydoxy-3-methyglutaryl coenzyme A reductase inhibitors and hepatic apo lipoprotein B secretion. Curr. Opin. Lipidol. 8: 138-145
15. Kannel, W. B., Sytkowsky, P. (1987) Atherosclerosis risk factors. Pharm. Ther. 32: 207-235
16. Krause, B. R., Princen, H. M. G. (1998) Lack of predictability of classical animal models for hypolipidemic activity: a good time for mice? Atherosclerosis 140: 15-24
17. Labarrios, F., Garduño, L., Vidal, M. R., García, R., Salazar, M., Martínez, E., Díaz, F., Chamorro, G., Tamariz, J. (1999) Synthesis and hypolipidemic evaluation of series of α-asarone analogues related to clofibrate in mice. J. Pharm. Pharmacol. 51: 1-7
18. López, M. L., Hernández, A., Chamorro, G., Mendoza-Figueroa, T. (1993) α-Asarone toxicity in long term cultures of adult rat hepatocytes. Planta Med. 59: 115-120
19. Meyers, C. D. Kashyap, M. L. (2004) Pharmacological elevation of high-density lipoproteins: recent insights on mechanism of action and atherosclerosis protection. Curr. Opin. Cardiol. 19: 366-373
20. Poplawski, J., Lozenweska, B., Dubis, A. T., Lachowska, B., Witkowski, S., Siluk, D., Petrusewski, J., Kaliszan, R., Cybulski, J., Strzalkowska, M., Chilmonczyk, Z. (2000) Synthesis and hypolipidaemic and antiplatelet activities of α-asarone isomers in humans (in vitro), mice (in vivo), and rats (in vivo). J. Med. Chem. 43: 3671-3676
21. Rodríguez-Páez, L., Juárez-Sánchez, M., Antúnez-Solis, J., Baeza, I., Wong, C. (2003) α-Asarone inhibits HMG-CoA reductase, lowers serum LDL-cholesterol levels and reduces biliary CSI in hypercholesterolemic rats. Phytomedicine 10: 397-404
22. Rubio-Poo, C., Lemini, C., García-Mondragon, J., Zavala, E., Silva, G., Mendoza-Patiño, N., Mandoki, J. J. (1991) The anticoagulant effect of beta-asarone in the mouse and the rat. Proc. West. Pharmacol. Soc. 34: 107-112
23. Safeer, R., S., Lacivita, C. L. (2000) Choosing drug therapy for patients with hyperlipemia. Am. Fam. Phys. 61: 3371-3382
24. Salazar, M., Salazar, S., Ulloa, V., Mendoza, T., Chamorro, G. (1992) Action tératogene de l'α-asarone chez la souris. J. Toxicol. Clin. Exp. 12: 149-154
25. Seri, K., Matsuo, T., Taniguchi, T., Amemiya, K., Kudo, M., Saito, G., Kato, T. (1980) Hypolipidemic affects of S-methylmethionine (vitamin U) using various experimental procedures. Arzneimittelforschung 30: 1694-1703
26. Silva, R. M., Santos, F. A., Maciel, M. A. M., Pinto, A. C., Rao, V. S. N. (2001) Effect of trans-dehydrocrotonin, a 19-nor-clerdone diterpene from Croton cajucara on experimental hypertriglyceridaemia and hypercholesterolaemia induced by triton WR 1339 (tyloxapol) in mice. Planta Med. 67: 763-765
27. Yang, J., Hua, W. Y., Wang, F. X., Wang, Z. Y., Wand, X. (2004) Design, synthesis, and inhibition of platelet aggregation for some 1-o-chlorophenyl-1,2, 3,4-tetrahydroisoquinoline derivatives. Bioorg. Med. Chem. 12: 6547-6557
28. Zúñiga, C., Garduño, L., Cruz, M. C., Salazar, M., Pérez-Pastén, R., Chamorro, G., Labarrios, F., Tamariz, J. (2005) Design of new potent hypolipidemic agents with the synergistic structural properties of α-asarone and fibrates. Drug Dev. Res. 64: 28-40